FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches
Published . Updated .
FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches PYMNTS.com
Directly affected
- No company is named in this report.
Indirectly affected
- XLE Energy Select Sector SPDR
Energy prices move when sanctioned supply is blocked
- USO United States Oil Fund
This fund moves with oil prices
- XOM Exxon Mobil
Oil producers move when sanctioned barrels leave the market
- CVX Chevron
Oil producers move when sanctioned barrels leave the market
- SLB SLB
Oilfield work in sanctioned regions can be cut off
- GLD SPDR Gold Shares
Gold is a usual haven when a conflict or sanction escalates
- LMT Lockheed Martin
Defense contractors get more work when conflict spending rises
- SPY SPDR S&P 500
The broad market moves when a major sanction lands
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches PYMNTS.com
Source: PYMNTS.com
Price since this story was published: Acadia Healthcare (ACHC)
Since the first closing price after “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches,” Acadia Healthcare (ACHC) is -4.55%. The S&P 500 fund (SPY) is -0.40% over the same days, a -4.15% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +0.50% | final price |
| Acadia Healthcare (ACHC) | the next day | +5.29% | final price |
| Acadia Healthcare (ACHC) | two days later | +3.19% | final price |
| Acadia Healthcare (ACHC) | three days later | -0.33% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -5.32% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -3.46% | final price |
| Ascendis Pharma A/S (ASND) | that day | -1.62% | final price |
| Ascendis Pharma A/S (ASND) | the next day | +0.04% | final price |
| Ascendis Pharma A/S (ASND) | two days later | -0.14% | final price |
| Ascendis Pharma A/S (ASND) | three days later | -0.76% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | -1.88% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | -0.35% | final price |
| CVX | that day | +1.30% | final price |
| CVX | the next day | +3.29% | final price |
| CVX | two days later | +2.02% | final price |
| CVX | three days later | +4.63% | final price |
| CVX | three days earlier | -1.61% | final price |
| CVX | five days earlier | -3.45% | final price |
| GLD | that day | -0.14% | final price |
| GLD | the next day | -1.62% | final price |
| GLD | two days later | +0.13% | final price |
| GLD | three days later | -0.03% | final price |
| GLD | three days earlier | -0.93% | final price |
| GLD | five days earlier | +0.03% | final price |
| LMT | that day | -1.60% | final price |
| LMT | the next day | +1.95% | final price |
| LMT | two days later | +4.06% | final price |
| LMT | three days later | +7.83% | final price |
| LMT | three days earlier | -0.82% | final price |
| LMT | five days earlier | -0.43% | final price |
Official trades in Acadia Healthcare (ACHC) around 13 Oct 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 14 days before publication, inside 30 days. The filing is listed beside the story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 32 days before publication, inside 60 days. The filing is listed beside the story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Acadia Healthcare (ACHC)
Companies tied to this story
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.” Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
Davita (DVA) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.” Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence in the 13 Oct 2026 story “FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches.” Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC)
“FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches” (13 Oct 2026) reaches Acadia Healthcare (ACHC) through this story.
Acadia Healthcare (ACHC) is on the page because GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Ascendis Pharma A/S (ASND), is listed for a different reason: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Acadia Healthcare (ACHC), and the dates in the story
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. ATYR traded between 0.17 and 0.41 across 20 sessions. The latest close on file is 0.17.
A simple score for Acadia Healthcare (ACHC)
46 out of 100
“FTC Seeks Sanctions Against Shkreli Over Alleged Pharma Ban Breaches” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.